Preventive trial of Homoeopathic medicines in COVID-19
Phase 3
Completed
- Registration Number
- CTRI/2020/11/029265
- Lead Sponsor
- Ministry of AYUSH Govt of India
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20000
Inclusion Criteria
a) Persons residing in the Tangra area of Kolkata
b) Age between 1 yr and 75 yrs
c) Participants of either sex
d) Written consent to participate (guardianâ??s consent in cases of minors)
Exclusion Criteria
a) Diagnosed or suspected cases of COVID-19
b) Currently suffering from flu-like illnesses
c) People who have already taken homoeoprophylaxis in some forms within last 30 days
d) Cases with vital organ failure
e) Immune compromised state
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Occurrence of newly diagnosed (laboratory confirmed by PCR) COVID-19 infection rates across the groupsTimepoint: Up to 30 days after completing the recommended dosage or once the person reports COVID-19 positive by PCR tests, whichever is earlier
- Secondary Outcome Measures
Name Time Method Occurrence of flu-like illnesses and/or clinically suspected cases of COVID-19 infections across the groupsTimepoint: Up to 30 days after completing the recommended dosage or once the person reports COVID-19 positive by PCR tests, whichever is earlier